Abstract
Ocular melanoma (OM) is a rare noncutaneous malignancy and consists of 2 different subtypes based on the anatomic location in the eye: uveal melanoma and conjunctival melanoma. Like cutaneous melanoma, OM benefits from nuclear medicine and molecular imaging in nodal staging and clinical management. Through the illustration of 2 distinctive cases, we aim to demonstrate the complementary roles of standard lymphoscintigraphy, advanced SPECT/CT, 18F-FDG PET/CT, and 18F-FDG PET/MRI in accurate nodal staging and surveillance of OM. We also review the epidemiology, existing staging guidelines, and management of uveal melanoma and conjunctival melanoma.
Original language | English (US) |
---|---|
Pages (from-to) | 275-280 |
Number of pages | 6 |
Journal | Journal of nuclear medicine technology |
Volume | 49 |
Issue number | 3 |
DOIs | |
State | Published - Sep 1 2021 |
Keywords
- F-FDG/PET
- SPECT
- conjunctival melanoma
- lymphoscintigraphy
- uveal melanoma
ASJC Scopus subject areas
- General Medicine